Vigabatrin in the treatment of infantile spasms

Pediatric Neurology

Volumn 20, Issue 2, 1999, Pages 106-110

  Koo, Betty ^a  

^a Children's Hospital   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOTROPIN; VIGABATRIN;

ARTICLE; CLINICAL ARTICLE; COGNITION; DOSE RESPONSE; DRUG EFFICACY; ELECTROENCEPHALOGRAM; FEMALE; HEART ARRHYTHMIA; HUMAN; HUMAN CELL; HUMAN TISSUE; INFANT; INFANTILE SPASM; MALE; NEWBORN; PATIENT MONITORING; PRIORITY JOURNAL;

ADRENOCORTICOTROPIC HORMONE; ANTICONVULSANTS; DRUG RESISTANCE; ELECTROENCEPHALOGRAPHY; FEMALE; GAMMA-AMINOBUTYRIC ACID; HUMANS; INFANT; MALE; RETROSPECTIVE STUDIES; SPASMS, INFANTILE; TIME FACTORS; TREATMENT OUTCOME; VIGABATRIN;

EID: 0033065579     PISSN: 08878994     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0887-8994(98)00116-7     Document Type: Article

References (30)

1. Chiron C., Dulac O., Beaumont D., Palacios L., Pajot N., Mumford J. Therapeutic trial of vigabatrin in refractory infantile spasms. J Child Neurol. 6:1991;2552-2559.
2. Appleton R.E. The role of vigabatrin in the management of infantile epileptic syndromes. Neurology. 43:(Suppl 5):1993;S21-S23.
3. del Giudice E., Latte F., Romano A. Vigabatrin in childhood epileptic syndromes (abstract). Seizure. 1:(Suppl A):1992;7-21.
4. Aicardi J., Sabril I.S., Mumford J.P., et al. Vigabatrin as initial therapy for infantile spasms A European retrospective survey . Epilepsia. 37:1996;638-642.
5. Koo B., Hwang P.A., Logan W.J. Infantile spasms Outcome and prognostic factors of cryptogenic and symptomatic groups . Neurology. 43:1993;2322-2327.
6. Haines S.T., Casto D.T. Treatment of infantile spasms. Ann Pharmacother. 28:1994;779-791.
7. Mumford J.P., Cannon D.J. Vigabatrin. Epilepsia. 35:(Suppl 5):1994;S25-S28.
8. van der Zwan A. Jr, van der Zwan A. Vigabatrin Results with a new antiepileptic agents in 57 patients in a general neurological practice (Dutch) . Ned Tijdschr Geneeskd. 138:1994;1859-1863.
9. Feucht M., Brantner-Inthaler S. Gamma-vinyl GABA (vigabatrin) in the therapy of Lennox-Gastaut syndrome An open study . Epilepsia. 35:1994;993-998.
10. Monaco F. Cognitive effects of vigabatrin A review . Neurology. 47:(suppl 1):1996;S6-S11.
11. Vigevano F., Cilio M.R. Vigabatrin versus ACTH as first-line treatment for infantile spasms A randomized, prospective study . Epilepsia. 38:1997;1270-1274.
12. Ben-Menachem E. Vigabatrin. Epilepsia. 36:(Suppl 2):1995;S95-S104.
13. Petroff O.A.G., Rothman D.L., Behar K.L., Mattson R.H. Human brain GABA levels rise after initiation of vigabatrin therapy but fail to rise further with increasing dose. Neurology. 46:1996;1459-1463.
14. Mattson R.H., Petroff O.A.C., Rothman D., Behar K. Vigabatrin Effect on brain GABA levels measured by nuclear magnetic resonance spectroscopy . Acta Neurol Scand Suppl. 162:1995;27.
15. Riikonen R. Infantile spasms Some new theoretical aspects . Epilepsia. 24:1983;159-168.
16. Lerman P., Kivity S. The efficacy of corticotrophin in primary infantile spasms. J Pediatr. 101:1982;294-296.
17. Rimmer E.M., Richens A. Double-blind study of gamma-vinyl GABA in patients with refractory epilepsy. Lancet. 1:1984;189-190.
18. Gram L., Klosterkov P., Dam M. Gamma-vinyl GABA A double-blind, placebo-controlled trial in partial epilepsy . Ann Neurol. 17:1985;262-266.
19. Loiseau P., Hardenberg J.P., Pestre M., Guyot M., Schechter P.J., Tell G.P. Double-blind placebo-controlled study of vigabatrin (gamma-vinyl GABA) in drug resistant epilepsy. Epilepsia. 27:1986;115-120.
20. Remy C., Favel P., Tell G. Double-blind, placebo-controlled, cross-over study of vigabatrin in drug resistant epilepsy of the adult. Boll Lega Ital Epil. 54/55:1986;241-243.
21. Tartara A., Manni A., Galimberti C.A., Hardenberg J., Orwin J., Perucca E. Vigabatrin in treatment of epilepsy A double-blind placebo-controlled study . Epilepsia. 27:1986;717-723.
22. Tassinari C.A., Michelucci R., Ambroseetto G., Salvi F. Double-blind study of vigabatrin in the treatment of drug resistant epilepsy. Arch Neurol. 44:1987;907-910.
23. Penry J.K., Wilder B.J., Sachdeo R.C., et al. Multicenter dose-response study of vigabatrin in adults with focal (partial) epilepsy. Epilepsia. 34:(Suppl 6):1993;67.
24. French J.A., Mosier M., Walker S., et al. A double-blind, placebo-controlled study of vigabatrin three g/day in patients with uncontrolled complex partial seizures Vigabatrin Protocol 024 Investigative Cohort . Neurology. 46:1996;54-61.
25. Srinivasan J., Richens A. A risk-benefit assessment of vigabatrin in the treatment of neurological disorders (review). Drug Saf. 10:1994;395-405.
26. Kalviainen R., Äikiä M., Saukkonen A.M., Pitkanen A., Riekkinen P.J. Sr. Vigabatrin vs carbamazepine monotherapy in patients with newly diagnosed epilepsy A randomized, controlled study . Arch Neurol. 52:1995;989-996.
27. Fisher R., Kälviäinen R., Tanganelli P., Regesta G. Newer antiepileptic drugs as monotherapy Data on vigabatrin . Neurology. 47:(Suppl S2):1996;5.
28. Vogt H., Kramer G. Vigabatrin and lamotrigin Experience with 2 new anticonvulsants in the Swiss epilepsy clinic (review) (German) . Schweiz Med Wochenschr. 125:1995;125-132.
29. Lortie A., Chiron C., Mumford J., Dulac O. The potential for increasing seizure frequency, relapse, and appearance of new seizure types with vigabatrin. Neurology. 43:(Suppl 5):1993;S24-S27.
30. Schmitt B., Wphlrab G., Boltshauser E. Vigabatrin in newly diagnosed infantile spasms. Neuropediatrics. 25:1994;54.